山西割痔疮疼不疼太原什么叫肛裂,山西上厕所滴血怎么回事,太原大便 出血 鲜红 不疼,山西的医院肛肠科,太原肛裂便血如何治疗,山西治痔疮的最佳方法,太原喝酒后大便出血是怎么回事

BEIJING, March 21 (Xinhuanet) -- A new device is being developed by American engineers to ease pain of blood sugar testing in diabetics, according to foreign media report last week.The upcoming device is the research target of a team of engineers at Arizona State University. It is specifically designed for patients with type1diabetes and type2 diabetes, according to a report in the "Journal of Diabetes Science and Technology,"  The traditional method of testing blood sugar levels involves painful pricks on the fingers to draw blood for testing. The inconvenient and painful process may somehow leave diabetics lax in their testing. The blood sugar levels, when poorly controlled, are very likely to trigger complications including heart disease, kidney disease and retinopathy.Unlike the old testing method, the new device could help people keep track of their blood sugar levels without the need to break the skin. It draws tears to measures the blood sugar levels in the fluid and gives just an accurate reading of blood sugar levels. "This new technology might encourage patients to check their blood sugars more often, which could lead to better control of their diabetes by a simple touch to the eye." said Jeffrey T. LaBelle, developer of the device.The new testing device has drawn great interest from investors due to its promising prospects. However, it still awaits a significant amount of testing before it can hit the market.

FUZHOU, Feb. 5 (Xinhua) -- A minibus rolled over and fell into a reservoir in Shaowu City in southeast China's Fujian Province Friday afternoon, killing 10, local officials said early Saturday morning.Nine people were rescued, and two were still missing.The minibus bound for Shaowu from Yong'an lost control at 5:27 p.m. Friday when the driver apparently tried to avoid a motorbike. It fell into the Qianling Hydropower Station reservoir, according to officials with Nanping city government.About 200 police and rescuers were still looking for the missing people, and the investigation into the accident is underway.

LOS ANGELES, April 4 (Xinhua) -- A woman's breast milk cells may be used to predict cancer in future research, according to a study published by HealthDay News on Monday.In the study, researchers at the University of Massachusetts in Amherst collected breast milk from 271 women in the United States. All had either undergone a biopsy of the breast to check for cancer, or were scheduled for one.The researchers evaluated breast milk samples from the biopsied and non-biopsied breasts.The researchers first isolated potentially cancerous cells, known as epithelial cells, and then isolated DNA to look for signals that regulate tumor suppresser genes.In the next step, the researchers analyzed three genes among the many known to undergo a process called methylation in breast cancer. Methylation in a specific region of a gene can inhibit or suppress the expression of a gene.For one gene, SFRP1, the average methylation was higher in the biopsied breast, the study found.Among the women whose biopsies detected cancer, average methylation of the RASSF1 gene in the biopsied breast was considerably higher compared to the non-biopsied breast.Among the women whose biopsies detected cancer, average methylation of the RASSF1 gene in the biopsied breast was considerably higher compared to the non-biopsied breast."It looks as if we can use the cells from breast milk to assess breast cancer risk," said Dr. Kathleen Arcaro, an associate professor of veterinary and animal sciences at the university.It's too soon, however, to assess the cancer detection rate associated with breast milk cell examination, she said."We can't say at this point for two reasons," she said. "One is, we need long-term follow-up. And the second really important reason is, we need to sample a larger panel of genes."Arcaro is to present her findings later Monday at the annual meeting of the American Association for Cancer Research in Orlando, Florida, according to HealthDay News.

MEXICO CITY, May 18 (Xinhua) -- The Mexican government signed an agreement with the non-governmental group TRAFFIC on Tuesday to exchange information about illegal seizures of flora and fauna species in Mexico.The agreement with the wildlife trade monitoring network also called for the Mexican government to provide information on the routes used to transport such organic materials.The agreement was signed on the sideline of the 16th meeting of the Trilateral Committee for Wildlife and Ecosystem Conservation Management in the city of Oaxaca, south Mexico. Representatives of Canada, the United States and Mexico also attended the meeting.Among the list of 20,000 animals, vegetation and insects that TRAFFIC considers to be threatened by illegal trafficking worldwide, 2,500 of the organisms have their origins in Mexico. This amounts to 12 percent of the species most subject to buying, selling and transporting in the black market and threatens the survival of various ecosystems.The Mexican species that are listed among the most threatened by illegal trafficking are the cactus, orchids, reptiles, maguey plants, ferns, amphibians and fish.

WASHINGTON, May 11 (Xinhua) -- Researchers at Brigham and Women 's Hospital (BWH), a teaching affiliate of Harvard Medical School, have identified a human lung stem cell that is self-renewing and capable of forming and integrating multiple biological structures of the lung. This research will be published Thursday in the New England Journal of Medicine."This research describes, for the first time, a true human lung stem cell. The discovery of this stem cell has the potential to offer those who suffer from chronic lung diseases a totally novel treatment option by regenerating or repairing damaged areas of the lung," said the study's corresponding author Piero Anversa, who is also director of the Center for Regenerative Medicine at the hospital.Using lung tissue from surgical samples, researchers identified and isolated the human lung stem cell and tested the functionality of the stem cell both in vitro and in vivo. Once the stem cell was isolated, researchers demonstrated in vitro that the cell was capable of dividing both into new stem cells and also into cells that would grow into various types of lung tissue. Next, researchers injected the stem cell into mice with damaged lungs. The injected stem cells differentiated into new bronchioles, alveoli and pulmonary vessel cells which not only formed new lung tissue, but also integrated structurally to the existing lung tissue in the mice.The researchers define this cell as truly "stem" because it fulfills the three categories necessary to fall under stem cell categorization: first, the cell renews itself; second, it forms into many different types of lung cells; and third, it is transmissible, meaning that after a mouse was injected with the stem cells and responded by generating new tissue, researchers were then able to isolate the stem cell in the treated mouse, and use that cell in a new mouse with the same results."These are the critical first steps in developing clinical treatments for those with lung disease for which no therapies exist. Further research is needed, but we are excited about the impact this discovery could have on our ability to regenerate or recreate new lung tissues to replace damaged areas of the lungs," said Joseph Loscalzo, chair of the Department of Medicine at BWH and co-author.